Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection-Reference-Cited by-同舟云学术

Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

Published:2005-06-10 Issue:5728 Volume:308 Page:1643-1645
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Chandran Kartik¹²³⁴,Sullivan Nancy J.¹²³⁴,Felbor Ute¹²³⁴,Whelan Sean P.¹²³⁴,Cunningham James M.¹²³⁴

Affiliation:

1. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

2. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

3. Institute of Human Genetics, Biozentrum, Am Hubland, D-97074 Würzburg, Germany.

4. Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.

Abstract

Ebola virus (EboV) causes rapidly fatal hemorrhagic fever in humans and there is currently no effective treatment. We found that the infection of African green monkey kidney (Vero) cells by vesicular stomatitis viruses bearing the EboV glycoprotein (GP) requires the activity of endosomal cysteine proteases. Using selective protease inhibitors and protease-deficient cell lines, we identified an essential role for cathepsin B (CatB) and an accessory role for cathepsin L (CatL) in EboV GP-dependent entry. Biochemical studies demonstrate that CatB and CatL mediate entry by carrying out proteolysis of the EboV GP subunit GP1 and support a multistep mechanism that explains the relative contributions of these enzymes to infection. CatB and CatB/CatL inhibitors diminish the multiplication of infectious EboV-Zaire in cultured cells and may merit investigation as anti-EboV drugs.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference29 articles.

1. T. W. Geisbert, P. B. Jahrling, Nat. Med.10, S110 (2004).

2. Characterization of Ebola Virus Entry by Using Pseudotyped Viruses: Identification of Receptor-Deficient Cell Lines

3. A system for functional analysis of Ebola virus glycoprotein

4. V. E. Volchkov, Curr. Top. Microbiol. Immunol.235, 35 (1999).

5. Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus

Cited by 715 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of universal Ebola virus vaccine candidates via immunofocusing;Proceedings of the National Academy of Sciences;2024-02-06

2. Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting;2024-01-04

3. Role of miRNA in Ebola diagnosis and therapeutics;MicroRNA in Human Infectious Diseases;2024

4. Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane;2023-12-22

5. Regulation of Ebola GP conformation and membrane binding by the chemical environment of the late endosome;PLOS Pathogens;2023-12-06